/ Print /

Health Management

Cancer MoonShot 2020 will arm oncologists with new tools
Cancer MoonShot 2020 will arm oncologists with new toolsThe Cancer MoonShot 2020 program brings together stakeholders from pharma, community and academic oncology, as well as government and scientific communities in an effort to accelerate the potential of combination immunotherapy as the next-generation standard of care in cancer patients.
Insurers benefit from getting on board with Cancer MoonShot 2020Drugs will be provided to health plan members on clinical trials free of charge.
New cancer care approach: Highmark’s cancer collaborativeCancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.
Obama’s precision medicine initiative: an updateThe precision medicine effort could dramatically change patient care, but will it be effective?
Four ways the genomic data commons will advance cancer careA new cancer database, the Genomic Data Commons, aims to make research more accessible
Health execs: How I feel about healthcare’s futureWe asked executives how they feel about the future of healthcare. Here’s what they said.
Payers Can Help with the Joy of MedicinePayers have a direct interest in preserving independent physician practices and helping all physicians regain the Joy of Medicine.
Four ways clinical decision support can improve outcomesThe advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are.
Three ways to rein in drug costs regardless of who becomes presidentIt’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation.
Are oncology pathways effective? AMCP presenters weigh inFaced with a proliferation of oncology treatments, payers have started using oncology pathways. But what do these programs look like, and are they really working?